Global Diabetes Devices Market By Offering [(Blood Glucose Monitoring and Insulin Delivery; By Blood Glucose Monitoring (Insulin Pumps, Injection Pens, Syringes and Jet injectors); By Insulin Delivery (Insulin Pumps, Injection Pens, Syringes and Jet injectors))]; By Operation Type (Invasive and Non-Invasive); By Sales Channel [(Online and Offline; By Online (E-Commerce and E-Pharmacies); By Offline (Hospital Pharmacies and Retail Pharmacies))]; By Application (Residential and Commercial); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Spain, Germany, Italy, Nordic Countries , Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Singapore, Philippines, Indonesia, Thailand, Malaysia, Vietnam, Rest of Southeast Asia), Brazil, Argentina, Rest of Latin America, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027
Industry Trends
Global diabetes devices market was valued at US$ 31,060.7 Mn in 2018 and is anticipated to reach US$ 60,100.6 Mn by 2027, growing at a CAGR of 7.6% over the forecast period. Sale of diabetes devices are witnessing increased demand owing to the rise in global population of diabetes patients. Diabetes is a disease in which pancreas, an organ of human body functions ineffectively and is unable to produce sufficient insulin, which is essential to absorb the glucose from food into body cells. Diabetic patients require external assistance to monitor and maintain safe blood sugar levels in their body. Diabetic devices assist humans to monitor and control their sugar levels and inject artificial insulin in their body as per requirement. Diabetes is most commonly observed in people with sedentary lifestyle and also in obese people.
Today’s work culture in urban areas involves less physical activity, hampering the natural insulin making process of body. Also, obesity causes insulin resistance in humans developing high risk of Type 2 diabetes. These factors have caused a stern rise in global diabetic population. A recent report published by Centers for Disease Control and Prevention (CDC) of the U.S states that in 2018 around 26.9 million citizens have diabetes which has increased to around 34.2 million U.S citizens Growing diabetic population increases demand for medical devices, thus propelling the growth of global diabetes devices market. The recent epidemic of COVID-19 has fuelled the growth in demand for diabetes devices. As the mortality rate of diabetes patients affected with coronavirus is high, increase in diabetes devices for monitoring and controlling diabetes has witnessed a surge thus propelling the market growth.
The fast paced lifestyle of today’s digital age has made the conventional diabetes monitoring devices and insulin delivery devices partially redundant. However, researchers have developed innovative diabetes devices with latest technology thus making the newly available solutions befitting. New devices have been introduced which are compatible with mobile phones, giving the user insightful data about his daily routine and alerts when the blood sugar level fluctuates. For instance, LifeScan IP Holdings, LLC introduced its diabetes management mobile app in November 2018, ‘OneTouch Reveal’ which monitors highs and lows in blood sugar levels and also alerts the user. This app is compatible with a range of OneTouch products. In other such instance, in 2015 Beta Bionics introduced closed loop bionic pancreas named iLet, which monitors the blood sugar levels and automatically delivers required amount of insulin. Such products with advantages of technology have made diabetes management hassle free thus increasing their popularity and adoption. Thus the advent of devices with cutting-edge technologies have fuelled the growth of diabetes devices market.
Offering Outlook:
Diabetes devices available in the market generally serve two purposes, monitoring of blood sugar levels or insulin delivery. Insulin delivery devices accounted for a large share of global diabetes devices market in 2018 owing to increase in number of Type 2 diabetes patients across the globe. Syringes and insulin pens are the most commonly used type of insulin delivery devices owing to lower cost as compared to other insulin delivery devices. Market players are introducing simple wearable insulin delivery devices to ease the hectic process of manual injection of insulin every time. For instance, Zealand Pharma US Inc. has introduced a wearable patch to deliver regulated amounts of insulin to human body over the day. These devices have transformed the insulin delivery and thus increased diabetes devices market, globally.
Along with insulin delivery, blood glucose monitoring devices also contribute a significant share in diabetes management. Blood glucose monitoring devices detect the sugar level in blood and alerts users to take corrective actions. Self-monitoring devices have contributed a significant share in global diabetes market, however continuous monitoring devices and sensors and transmitters are gaining momentum and are anticipated to grow at higher CAGR over the forecast period. The continuous monitoring devices have enabled closed loop diabetes systems eliminating the human intervention either for monitoring or insulin delivery. For instance, in December 2019, Food and Drug Administration (FDA) approved a new technology of Tandem Diabetes Care called Control-IQ which connects glucose monitoring sensors and insulin pumps to control the amount of insulin delivery automatically as per requirement. Such inventions are anticipated to pose potential opportunities and drive the global diabetes devices market over forecast years.
Operation Type Outlook
As per the operation type, the diabetes devices market is segmented in two types, invasive and non-invasive. Invasive is introducing needles or lancets in a body and non-invasive is without introducing any object in a body. Invasive devices held a large share of global diabetic devices market in 2018 owing to faster and higher efficiency. However, the messy operation of the strips, blood, lancets in the invasive devices has forced diabetic patients to opt for non-invasive devices. The non-invasive blood glucose monitors such as finger sensor from DiaMonTech AG, GlucoTrack from Integrity Applications and many such other devices are gaining increased popularity owing to the hassle free operation. Also, the non-invasive insulin delivery devices including jet injectors are performing overwhelmingly in the market. For instance, the InsuJet uses needle free nozzle which creates a stream of insulin and it penetrates through skin. Also, inhaled insulin has been in the market for long time and researchers are developing effective solutions using this method. Thus, the development of non-invasive devices are poised to propel the global diabetes devices market.
Sales Channel Outlook
The physical or offline sales channel contribute significant share in global diabetes devices market of 2018. Online distribution channels are anticipated to show higher growth rate over the forecast years compared to offline channels. The changing lifestyle and shopping habits of global population supplemented by increasing number of online resources such as e-commerce websites and e-pharmacies have added to the growth rate of online channels in diabetes devices market. Also, the recent epidemic of COVID-19 has boosted online shopping activities thus further propelling the online sales segment.
Application Outlook
Residential sale of diabetes devices contributed to a noteworthy share of global diabetes devices market in 2018 owing to rise in awareness for diabetes care and also initiatives by government entities supporting diabetes management. For instance, U.S. Department of Health and Human Services provides Medicare federal health insurance which covers costs for diabetes supplies such as glucose monitors, test strips, lancets and others. Thus the rise in awareness for diabetes management is driving the growth of global diabetes devices market.
Regional Outlook:
North America held a prominent market in global diabetes devices market owing to rise in number of diabetic population coupled with expenditure power of the population in the region. Asia Pacific region is anticipated to register highest growth rate over the forecast period owing to growing obese and diabetic population coupled with government initiatives. For instance, nations such as India, Australia, and others have initiated programs to raise awareness about diabetes and control the number of diabetes patients in hospitals. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Diabetes Devices Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of diabetes devices market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the diabetes devices market are Abbott, Arkray, Inc., B. Braun Melsungen AG, Bayer Corporation, BD, Dexcom Inc., F Hoffmann-La Roche Ag, iHealth Labs Inc., InsuJet, Insulet Corporation, Integrity Applications, LifeScan, Inc., Medtronic, Nemaura, Novo Nordisk, Sanofi, Tandem, Valeritas Holdings Inc., Ypsomed Holding AG amongst other market participants.
Global Diabetes Devices Market:
By Offering
- Blood Glucose Monitoring
- Continuous Glucose Monitors
- Self-monitoring Meters
- Sensors and Transmitters
- Insulin Delivery
- Insulin Pumps
- Injection Pens
- Syringes
- Jet injectors
By Operation Type
- Invasive
- Non-Invasive
By Sales Channel
- Online
- E-Commerce
- E-Pharmacies
- Offline
- Hospital Pharmacies
- Retail Pharmacies
By Application
- Residential
- Commercial (Hospitals, Labs, etc.)
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2013 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Diabetes Devices Market
6. Market Synopsis:
Diabetes Devices Market
7. Diabetes Devices Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
Diabetes Devices Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Diabetes Devices Market
7.6. Industry
Gross Margin Overview
7.7. Porter’s
Five Force Analysis
7.8. PESTEL
Analysis
7.9. Value
Chain Analysis
7.10. Pricing
Analysis, By Region (2017 and 2018)
7.10.1. North
America
7.10.1.1. U.S
7.10.1.2. Canada
7.10.1.3. Mexico
7.10.1.4. Rest of North America
7.10.2. Europe
7.10.2.1. France
7.10.2.2. The UK
7.10.2.3. Spain
7.10.2.4. Germany
7.10.2.5. Italy
7.10.2.6. Nordic Countries
7.10.2.6.1. Denmark
7.10.2.6.2. Finland
7.10.2.6.3. Iceland
7.10.2.6.4. Sweden
7.10.2.6.5. Norway
7.10.2.7. Benelux Union
7.10.2.7.1. Belgium
7.10.2.7.2. The Netherlands
7.10.2.7.3. Luxembourg
7.10.2.8. Rest of Europe
7.10.3. Asia
Pacific
7.10.3.1. China
7.10.3.2. Japan
7.10.3.3. India
7.10.3.4. New Zealand
7.10.3.5. Australia
7.10.3.6. South Korea
7.10.3.7. Southeast Asia
7.10.3.7.1. Indonesia
7.10.3.7.2. Thailand
7.10.3.7.3. Malaysia
7.10.3.7.4. Singapore
7.10.3.7.5. Rest of Southeast Asia
7.10.3.8. Rest of Asia Pacific
7.10.4. Middle
East and Africa
7.10.4.1. Saudi Arabia
7.10.4.2. UAE
7.10.4.3. Egypt
7.10.4.4. Kuwait
7.10.4.5. South Africa
7.10.4.6. Rest of Middle East & Africa
7.10.5. Latin
America
7.10.5.1. Brazil
7.10.5.2. Argentina
7.10.5.3. Rest of Latin America
8. Global Diabetes Devices Market Analysis and Forecasts, 2019 –
2027
8.1. Overview
8.1.1. Global
Diabetes Devices Market Revenue (US$ Mn)
8.2. Global
Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Offering
8.2.1. Blood
Glucose Monitoring (Definition, Market Estimation and Penetration, 2013 – 2018,
Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual
Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific,
Middle East and Africa, Latin America) and Information on Continuous Glucose
Monitors, Self-monitoring Meters, Sensors and Transmitters)
8.2.1.1. Continuous Glucose Monitors
8.2.1.2. Self-monitoring Meters
8.2.1.3. Sensors and Transmitters
8.2.2. Insulin
Delivery (Definition, Market Estimation and Penetration, 2013 – 2018, Market
Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Insulin Pumps, Injection
Pens, Syringes, Jet injectors)
8.2.2.1. Insulin Pumps
8.2.2.2. Injection Pens
8.2.2.3. Syringes
8.2.2.4. Jet injectors
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offering
9. Global Diabetes Devices Market Analysis and Forecasts, 2019 –
2027
9.1. Overview
9.2. Global
Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Operation Type
9.2.1. Invasive
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2013 – 2018
9.2.1.3. Market Forecast, 2019 – 2027
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2013 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2013 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2013 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2013 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2013 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. Non-Invasive
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2013 – 2018
9.2.2.3. Market Forecast, 2019 – 2027
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2013 – 2018
9.2.2.5.1.2. Market
Forecast, 2019 – 2027
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2013 – 2018
9.2.2.5.2.2. Market
Forecast, 2019 – 2027
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2013 – 2018
9.2.2.5.3.2. Market
Forecast, 2019 – 2027
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2013 – 2018
9.2.2.5.4.2. Market
Forecast, 2019 – 2027
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2013 – 2018
9.2.2.5.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By
Operation Type
10. Global Diabetes Devices Market Analysis and Forecasts, 2019 –
2027
10.1. Overview
10.2. Global
Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Sales Channel
10.2.1. Online
(Definition, Market Estimation and Penetration, 2013 – 2018, Market Estimation
(2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR),
Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and
Africa, Latin America) and Information on E-Commerce, E-Pharmacies)
10.2.1.1. E-Commerce
10.2.1.2. E-Pharmacies
10.2.2. Offline
(Definition, Market Estimation and Penetration, 2013 – 2018, Market Estimation
(2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Hospital Pharmacies, Retail
Pharmacies)
10.2.2.1. Hospital Pharmacies
10.2.2.2. Retail Pharmacies
10.3. Key
Segment for Channeling Investments
10.3.1. By
Sales Channel
11. Global Diabetes Devices Market Analysis and Forecasts, 2019 –
2027
11.1. Overview
11.2. Global
Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Application
11.2.1. Residential
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2013 – 2018
11.2.1.3. Market Forecast, 2019 – 2027
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2013 – 2018
11.2.1.5.1.2. Market
Forecast, 2019 – 2027
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2013 – 2018
11.2.1.5.2.2. Market
Forecast, 2019 – 2027
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2013 – 2018
11.2.1.5.3.2. Market
Forecast, 2019 – 2027
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2013 – 2018
11.2.1.5.4.2. Market
Forecast, 2019 – 2027
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2013 – 2018
11.2.1.5.5.2. Market
Forecast, 2019 – 2027
11.2.2. Commercial
(Hospitals, Labs, etc.)
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2013 – 2018
11.2.2.3. Market Forecast, 2019 – 2027
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2013 – 2018
11.2.2.5.1.2. Market
Forecast, 2019 – 2027
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2013 – 2018
11.2.2.5.2.2. Market
Forecast, 2019 – 2027
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2013 – 2018
11.2.2.5.3.2. Market
Forecast, 2019 – 2027
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2013 – 2018
11.2.2.5.4.2. Market
Forecast, 2019 – 2027
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2013 – 2018
11.2.2.5.5.2. Market
Forecast, 2019 – 2027
11.3. Key
Segment for Channeling Investments
11.3.1. By
Application
12. North America Diabetes Devices Market Analysis and Forecasts,
2019 - 2027
12.1. Overview
12.1.1. North
America Diabetes Devices Market Revenue (US$ Mn)
12.2. North
America Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Offering
12.2.1. Blood
Glucose Monitoring
12.2.1.1. Continuous Glucose Monitors
12.2.1.2. Self-monitoring Meters
12.2.1.3. Sensors and Transmitters
12.2.2. Insulin
Delivery
12.2.2.1. Insulin Pumps
12.2.2.2. Injection Pens
12.2.2.3. Syringes
12.2.2.4. Jet injectors
12.3. North
America Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Operation
Type
12.3.1. Invasive
12.3.2. Non-Invasive
12.4. North
America Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Sales
Channel
12.4.1. Online
12.4.1.1. E-Commerce
12.4.1.2. E-Pharmacies
12.4.2. Offline
12.4.2.1. Hospital Pharmacies
12.4.2.2. Retail Pharmacies
12.5. North
America Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1. Residential
12.5.2. Commercial
(Hospitals, Labs, etc.)
12.6. North
America Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Offering
12.6.1.1.1. Blood Glucose Monitoring
12.6.1.1.1.1. Continuous
Glucose Monitors
12.6.1.1.1.2. Self-monitoring
Meters
12.6.1.1.1.3. Sensors
and Transmitters
12.6.1.1.2. Insulin Delivery
12.6.1.1.2.1. Insulin
Pumps
12.6.1.1.2.2. Injection
Pens
12.6.1.1.2.3. Syringes
12.6.1.1.2.4. Jet
injectors
12.6.1.2. U.S Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Operation Type
12.6.1.2.1. Invasive
12.6.1.2.2. Non-Invasive
12.6.1.3. U.S Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Sales Channel
12.6.1.3.1. Online
12.6.1.3.1.1. E-Commerce
12.6.1.3.1.2. E-Pharmacies
12.6.1.3.2. Offline
12.6.1.3.2.1. Hospital
Pharmacies
12.6.1.3.2.2. Retail
Pharmacies
12.6.1.4. U.S Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Application
12.6.1.4.1. Residential
12.6.1.4.2. Commercial (Hospitals, Labs, etc.)
12.6.2. Canada
12.6.2.1. Canada Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
12.6.2.1.1. Blood Glucose Monitoring
12.6.2.1.1.1. Continuous
Glucose Monitors
12.6.2.1.1.2. Self-monitoring
Meters
12.6.2.1.1.3. Sensors
and Transmitters
12.6.2.1.2. Insulin Delivery
12.6.2.1.2.1. Insulin
Pumps
12.6.2.1.2.2. Injection
Pens
12.6.2.1.2.3. Syringes
12.6.2.1.2.4. Jet
injectors
12.6.2.2. Canada Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
12.6.2.2.1. Invasive
12.6.2.2.2. Non-Invasive
12.6.2.3. Canada Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
12.6.2.3.1. Online
12.6.2.3.1.1. E-Commerce
12.6.2.3.1.2. E-Pharmacies
12.6.2.3.2. Offline
12.6.2.3.2.1. Hospital
Pharmacies
12.6.2.3.2.2. Retail
Pharmacies
12.6.2.4. Canada Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
12.6.2.4.1. Residential
12.6.2.4.2. Commercial (Hospitals, Labs, etc.)
12.6.3. Mexico
12.6.3.1. Mexico Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
12.6.3.1.1. Blood Glucose Monitoring
12.6.3.1.1.1. Continuous
Glucose Monitors
12.6.3.1.1.2. Self-monitoring
Meters
12.6.3.1.1.3. Sensors
and Transmitters
12.6.3.1.2. Insulin Delivery
12.6.3.1.2.1. Insulin
Pumps
12.6.3.1.2.2. Injection
Pens
12.6.3.1.2.3. Syringes
12.6.3.1.2.4. Jet
injectors
12.6.3.2. Mexico Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
12.6.3.2.1. Invasive
12.6.3.2.2. Non-Invasive
12.6.3.3. Mexico Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
12.6.3.3.1. Online
12.6.3.3.1.1. E-Commerce
12.6.3.3.1.2. E-Pharmacies
12.6.3.3.2. Offline
12.6.3.3.2.1. Hospital
Pharmacies
12.6.3.3.2.2. Retail
Pharmacies
12.6.3.4. Mexico Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
12.6.3.4.1. Residential
12.6.3.4.2. Commercial (Hospitals, Labs, etc.)
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Offering
12.6.4.1.1. Blood Glucose Monitoring
12.6.4.1.1.1. Continuous
Glucose Monitors
12.6.4.1.1.2. Self-monitoring
Meters
12.6.4.1.1.3. Sensors
and Transmitters
12.6.4.1.2. Insulin Delivery
12.6.4.1.2.1. Insulin
Pumps
12.6.4.1.2.2. Injection
Pens
12.6.4.1.2.3. Syringes
12.6.4.1.2.4. Jet
injectors
12.6.4.2. Rest of North America Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Operation Type
12.6.4.2.1. Invasive
12.6.4.2.2. Non-Invasive
12.6.4.3. Rest of North America Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
12.6.4.3.1. Online
12.6.4.3.1.1. E-Commerce
12.6.4.3.1.2. E-Pharmacies
12.6.4.3.2. Offline
12.6.4.3.2.1. Hospital
Pharmacies
12.6.4.3.2.2. Retail
Pharmacies
12.6.4.4. Rest of North America Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Application
12.6.4.4.1. Residential
12.6.4.4.2. Commercial (Hospitals, Labs, etc.)
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Offering
12.7.3. By
Operation Type
12.7.4. By
Sales Channel
12.7.5. By
Application
13. Europe Diabetes Devices Market Analysis and Forecasts, 2019 -
2027
13.1. Overview
13.1.1. Europe
Diabetes Devices Market Revenue (US$ Mn)
13.2. Europe
Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Offering
13.2.1. Blood
Glucose Monitoring
13.2.1.1. Continuous Glucose Monitors
13.2.1.2. Self-monitoring Meters
13.2.1.3. Sensors and Transmitters
13.2.2. Insulin
Delivery
13.2.2.1. Insulin Pumps
13.2.2.2. Injection Pens
13.2.2.3. Syringes
13.2.2.4. Jet injectors
13.3. Europe
Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Operation Type
13.3.1. Invasive
13.3.2. Non-Invasive
13.4. Europe
Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Sales Channel
13.4.1. Online
13.4.1.1. E-Commerce
13.4.1.2. E-Pharmacies
13.4.2. Offline
13.4.2.1. Hospital Pharmacies
13.4.2.2. Retail Pharmacies
13.5. Europe
Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1. Residential
13.5.2. Commercial
(Hospitals, Labs, etc.)
13.6. Europe
Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
13.6.1.1.1. Blood Glucose Monitoring
13.6.1.1.1.1. Continuous
Glucose Monitors
13.6.1.1.1.2. Self-monitoring
Meters
13.6.1.1.1.3. Sensors
and Transmitters
13.6.1.1.2. Insulin Delivery
13.6.1.1.2.1. Insulin
Pumps
13.6.1.1.2.2. Injection
Pens
13.6.1.1.2.3. Syringes
13.6.1.1.2.4. Jet
injectors
13.6.1.2. France Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
13.6.1.2.1. Invasive
13.6.1.2.2. Non-Invasive
13.6.1.3. France Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
13.6.1.3.1. Online
13.6.1.3.1.1. E-Commerce
13.6.1.3.1.2. E-Pharmacies
13.6.1.3.2. Offline
13.6.1.3.2.1. Hospital
Pharmacies
13.6.1.3.2.2. Retail
Pharmacies
13.6.1.4. France Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.1.4.1. Residential
13.6.1.4.2. Commercial (Hospitals, Labs, etc.)
13.6.2. The UK
13.6.2.1. The UK Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
13.6.2.1.1. Blood Glucose Monitoring
13.6.2.1.1.1. Continuous
Glucose Monitors
13.6.2.1.1.2. Self-monitoring
Meters
13.6.2.1.1.3. Sensors
and Transmitters
13.6.2.1.2. Insulin Delivery
13.6.2.1.2.1. Insulin
Pumps
13.6.2.1.2.2. Injection
Pens
13.6.2.1.2.3. Syringes
13.6.2.1.2.4. Jet
injectors
13.6.2.2. The UK Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
13.6.2.2.1. Invasive
13.6.2.2.2. Non-Invasive
13.6.2.3. The UK Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
13.6.2.3.1. Online
13.6.2.3.1.1. E-Commerce
13.6.2.3.1.2. E-Pharmacies
13.6.2.3.2. Offline
13.6.2.3.2.1. Hospital
Pharmacies
13.6.2.3.2.2. Retail
Pharmacies
13.6.2.4. The UK Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.2.4.1. Residential
13.6.2.4.2. Commercial (Hospitals, Labs, etc.)
13.6.3. Spain
13.6.3.1. Spain Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
13.6.3.1.1. Blood Glucose Monitoring
13.6.3.1.1.1. Continuous
Glucose Monitors
13.6.3.1.1.2. Self-monitoring
Meters
13.6.3.1.1.3. Sensors
and Transmitters
13.6.3.1.2. Insulin Delivery
13.6.3.1.2.1. Insulin
Pumps
13.6.3.1.2.2. Injection
Pens
13.6.3.1.2.3. Syringes
13.6.3.1.2.4. Jet
injectors
13.6.3.2. Spain Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
13.6.3.2.1. Invasive
13.6.3.2.2. Non-Invasive
13.6.3.3. Spain Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
13.6.3.3.1. Online
13.6.3.3.1.1. E-Commerce
13.6.3.3.1.2. E-Pharmacies
13.6.3.3.2. Offline
13.6.3.3.2.1. Hospital
Pharmacies
13.6.3.3.2.2. Retail
Pharmacies
13.6.3.4. Spain Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.3.4.1. Residential
13.6.3.4.2. Commercial (Hospitals, Labs, etc.)
13.6.4. Germany
13.6.4.1. Germany Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.4.1.1. Blood Glucose Monitoring
13.6.4.1.1.1. Continuous
Glucose Monitors
13.6.4.1.1.2. Self-monitoring
Meters
13.6.4.1.1.3. Sensors
and Transmitters
13.6.4.1.2. Insulin Delivery
13.6.4.1.2.1. Insulin
Pumps
13.6.4.1.2.2. Injection
Pens
13.6.4.1.2.3. Syringes
13.6.4.1.2.4. Jet
injectors
13.6.4.2. Germany Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Operation Type
13.6.4.2.1. Invasive
13.6.4.2.2. Non-Invasive
13.6.4.3. Germany Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
13.6.4.3.1. Online
13.6.4.3.1.1. E-Commerce
13.6.4.3.1.2. E-Pharmacies
13.6.4.3.2. Offline
13.6.4.3.2.1. Hospital
Pharmacies
13.6.4.3.2.2. Retail
Pharmacies
13.6.4.4. Germany Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.4.4.1. Residential
13.6.4.4.2. Commercial (Hospitals, Labs, etc.)
13.6.5. Italy
13.6.5.1. Italy Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
13.6.5.1.1. Blood Glucose Monitoring
13.6.5.1.1.1. Continuous
Glucose Monitors
13.6.5.1.1.2. Self-monitoring
Meters
13.6.5.1.1.3. Sensors
and Transmitters
13.6.5.1.2. Insulin Delivery
13.6.5.1.2.1. Insulin
Pumps
13.6.5.1.2.2. Injection
Pens
13.6.5.1.2.3. Syringes
13.6.5.1.2.4. Jet
injectors
13.6.5.2. Italy Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
13.6.5.2.1. Invasive
13.6.5.2.2. Non-Invasive
13.6.5.3. Italy Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
13.6.5.3.1. Online
13.6.5.3.1.1. E-Commerce
13.6.5.3.1.2. E-Pharmacies
13.6.5.3.2. Offline
13.6.5.3.2.1. Hospital
Pharmacies
13.6.5.3.2.2. Retail
Pharmacies
13.6.5.4. Italy Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.5.4.1. Residential
13.6.5.4.2. Commercial (Hospitals, Labs, etc.)
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.6.1.1. Blood Glucose Monitoring
13.6.6.1.1.1. Continuous
Glucose Monitors
13.6.6.1.1.2. Self-monitoring
Meters
13.6.6.1.1.3. Sensors
and Transmitters
13.6.6.1.2. Insulin Delivery
13.6.6.1.2.1. Insulin
Pumps
13.6.6.1.2.2. Injection
Pens
13.6.6.1.2.3. Syringes
13.6.6.1.2.4. Jet
injectors
13.6.6.2. Nordic Countries Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Operation Type
13.6.6.2.1. Invasive
13.6.6.2.2. Non-Invasive
13.6.6.3. Nordic Countries Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
13.6.6.3.1. Online
13.6.6.3.1.1. E-Commerce
13.6.6.3.1.2. E-Pharmacies
13.6.6.3.2. Offline
13.6.6.3.2.1. Hospital
Pharmacies
13.6.6.3.2.2. Retail
Pharmacies
13.6.6.4. Nordic Countries Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.6.4.1. Residential
13.6.6.4.2. Commercial (Hospitals, Labs, etc.)
13.6.6.5. Nordic Countries Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
13.6.7.1.1. Blood Glucose Monitoring
13.6.7.1.1.1. Continuous
Glucose Monitors
13.6.7.1.1.2. Self-monitoring
Meters
13.6.7.1.1.3. Sensors
and Transmitters
13.6.7.1.2. Insulin Delivery
13.6.7.1.2.1. Insulin
Pumps
13.6.7.1.2.2. Injection
Pens
13.6.7.1.2.3. Syringes
13.6.7.1.2.4. Jet
injectors
13.6.7.2. Benelux Union Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
13.6.7.2.1. Invasive
13.6.7.2.2. Non-Invasive
13.6.7.3. Benelux Union Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
13.6.7.3.1. Online
13.6.7.3.1.1. E-Commerce
13.6.7.3.1.2. E-Pharmacies
13.6.7.3.2. Offline
13.6.7.3.2.1. Hospital
Pharmacies
13.6.7.3.2.2. Retail
Pharmacies
13.6.7.4. Benelux Union Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.7.4.1. Residential
13.6.7.4.2. Commercial (Hospitals, Labs, etc.)
13.6.7.5. Benelux Union Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.8.1.1. Blood Glucose Monitoring
13.6.8.1.1.1. Continuous
Glucose Monitors
13.6.8.1.1.2. Self-monitoring
Meters
13.6.8.1.1.3. Sensors
and Transmitters
13.6.8.1.2. Insulin Delivery
13.6.8.1.2.1. Insulin
Pumps
13.6.8.1.2.2. Injection
Pens
13.6.8.1.2.3. Syringes
13.6.8.1.2.4. Jet
injectors
13.6.8.2. Rest of Europe Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Operation Type
13.6.8.2.1. Invasive
13.6.8.2.2. Non-Invasive
13.6.8.3. Rest of Europe Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
13.6.8.3.1. Online
13.6.8.3.1.1. E-Commerce
13.6.8.3.1.2. E-Pharmacies
13.6.8.3.2. Offline
13.6.8.3.2.1. Hospital
Pharmacies
13.6.8.3.2.2. Retail
Pharmacies
13.6.8.4. Rest of Europe Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.8.4.1. Residential
13.6.8.4.2. Commercial (Hospitals, Labs, etc.)
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Offering
13.7.3. By
Operation Type
13.7.4. By
Sales Channel
13.7.5. By
Application
14. Asia Pacific Diabetes Devices Market Analysis and Forecasts,
2019 - 2027
14.1. Overview
14.1.1. Asia
Pacific Diabetes Devices Market Revenue (US$ Mn)
14.2. Asia
Pacific Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Offering
14.2.1. Blood
Glucose Monitoring
14.2.1.1. Continuous Glucose Monitors
14.2.1.2. Self-monitoring Meters
14.2.1.3. Sensors and Transmitters
14.2.2. Insulin
Delivery
14.2.2.1. Insulin Pumps
14.2.2.2. Injection Pens
14.2.2.3. Syringes
14.2.2.4. Jet injectors
14.3. Asia
Pacific Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Operation
Type
14.3.1. Invasive
14.3.2. Non-Invasive
14.4. Asia
Pacific Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Sales
Channel
14.4.1. Online
14.4.1.1. E-Commerce
14.4.1.2. E-Pharmacies
14.4.2. Offline
14.4.2.1. Hospital Pharmacies
14.4.2.2. Retail Pharmacies
14.5. Asia
Pacific Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Application
14.5.1. Residential
14.5.2. Commercial
(Hospitals, Labs, etc.)
14.6. Asia
Pacific Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
14.6.1.1.1. Blood Glucose Monitoring
14.6.1.1.1.1. Continuous
Glucose Monitors
14.6.1.1.1.2. Self-monitoring
Meters
14.6.1.1.1.3. Sensors
and Transmitters
14.6.1.1.2. Insulin Delivery
14.6.1.1.2.1. Insulin
Pumps
14.6.1.1.2.2. Injection
Pens
14.6.1.1.2.3. Syringes
14.6.1.1.2.4. Jet
injectors
14.6.1.2. China Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
14.6.1.2.1. Invasive
14.6.1.2.2. Non-Invasive
14.6.1.3. China Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
14.6.1.3.1. Online
14.6.1.3.1.1. E-Commerce
14.6.1.3.1.2. E-Pharmacies
14.6.1.3.2. Offline
14.6.1.3.2.1. Hospital
Pharmacies
14.6.1.3.2.2. Retail
Pharmacies
14.6.1.4. China Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
14.6.1.4.1. Residential
14.6.1.4.2. Commercial (Hospitals, Labs, etc.)
14.6.2. Japan
14.6.2.1. Japan Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
14.6.2.1.1. Blood Glucose Monitoring
14.6.2.1.1.1. Continuous
Glucose Monitors
14.6.2.1.1.2. Self-monitoring
Meters
14.6.2.1.1.3. Sensors
and Transmitters
14.6.2.1.2. Insulin Delivery
14.6.2.1.2.1. Insulin
Pumps
14.6.2.1.2.2. Injection
Pens
14.6.2.1.2.3. Syringes
14.6.2.1.2.4. Jet
injectors
14.6.2.2. Japan Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
14.6.2.2.1. Invasive
14.6.2.2.2. Non-Invasive
14.6.2.3. Japan Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
14.6.2.3.1. Online
14.6.2.3.1.1. E-Commerce
14.6.2.3.1.2. E-Pharmacies
14.6.2.3.2. Offline
14.6.2.3.2.1. Hospital
Pharmacies
14.6.2.3.2.2. Retail
Pharmacies
14.6.2.4. Japan Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
14.6.2.4.1. Residential
14.6.2.4.2. Commercial (Hospitals, Labs, etc.)
14.6.3. India
14.6.3.1. India Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
14.6.3.1.1. Blood Glucose Monitoring
14.6.3.1.1.1. Continuous
Glucose Monitors
14.6.3.1.1.2. Self-monitoring
Meters
14.6.3.1.1.3. Sensors
and Transmitters
14.6.3.1.2. Insulin Delivery
14.6.3.1.2.1. Insulin
Pumps
14.6.3.1.2.2. Injection
Pens
14.6.3.1.2.3. Syringes
14.6.3.1.2.4. Jet
injectors
14.6.3.2. India Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
14.6.3.2.1. Invasive
14.6.3.2.2. Non-Invasive
14.6.3.3. India Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
14.6.3.3.1. Online
14.6.3.3.1.1. E-Commerce
14.6.3.3.1.2. E-Pharmacies
14.6.3.3.2. Offline
14.6.3.3.2.1. Hospital
Pharmacies
14.6.3.3.2.2. Retail
Pharmacies
14.6.3.4. India Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
14.6.3.4.1. Residential
14.6.3.4.2. Commercial (Hospitals, Labs, etc.)
14.6.4. New
Zealand
14.6.4.1. New Zealand Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.4.1.1. Blood Glucose Monitoring
14.6.4.1.1.1. Continuous
Glucose Monitors
14.6.4.1.1.2. Self-monitoring
Meters
14.6.4.1.1.3. Sensors
and Transmitters
14.6.4.1.2. Insulin Delivery
14.6.4.1.2.1. Insulin
Pumps
14.6.4.1.2.2. Injection
Pens
14.6.4.1.2.3. Syringes
14.6.4.1.2.4. Jet
injectors
14.6.4.2. New Zealand Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Operation Type
14.6.4.2.1. Invasive
14.6.4.2.2. Non-Invasive
14.6.4.3. New Zealand Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
14.6.4.3.1. Online
14.6.4.3.1.1. E-Commerce
14.6.4.3.1.2. E-Pharmacies
14.6.4.3.2. Offline
14.6.4.3.2.1. Hospital
Pharmacies
14.6.4.3.2.2. Retail
Pharmacies
14.6.4.4. New Zealand Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.4.4.1. Residential
14.6.4.4.2. Commercial (Hospitals, Labs, etc.)
14.6.5. Australia
14.6.5.1. Australia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.5.1.1. Blood Glucose Monitoring
14.6.5.1.1.1. Continuous
Glucose Monitors
14.6.5.1.1.2. Self-monitoring
Meters
14.6.5.1.1.3. Sensors
and Transmitters
14.6.5.1.2. Insulin Delivery
14.6.5.1.2.1. Insulin
Pumps
14.6.5.1.2.2. Injection
Pens
14.6.5.1.2.3. Syringes
14.6.5.1.2.4. Jet
injectors
14.6.5.2. Australia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Operation Type
14.6.5.2.1. Invasive
14.6.5.2.2. Non-Invasive
14.6.5.3. Australia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
14.6.5.3.1. Online
14.6.5.3.1.1. E-Commerce
14.6.5.3.1.2. E-Pharmacies
14.6.5.3.2. Offline
14.6.5.3.2.1. Hospital
Pharmacies
14.6.5.3.2.2. Retail
Pharmacies
14.6.5.4. Australia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.5.4.1. Residential
14.6.5.4.2. Commercial (Hospitals, Labs, etc.)
14.6.6. South
Korea
14.6.6.1. South Korea Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.6.1.1. Blood Glucose Monitoring
14.6.6.1.1.1. Continuous
Glucose Monitors
14.6.6.1.1.2. Self-monitoring
Meters
14.6.6.1.1.3. Sensors
and Transmitters
14.6.6.1.2. Insulin Delivery
14.6.6.1.2.1. Insulin
Pumps
14.6.6.1.2.2. Injection
Pens
14.6.6.1.2.3. Syringes
14.6.6.1.2.4. Jet
injectors
14.6.6.2. South Korea Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Operation Type
14.6.6.2.1. Invasive
14.6.6.2.2. Non-Invasive
14.6.6.3. South Korea Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
14.6.6.3.1. Online
14.6.6.3.1.1. E-Commerce
14.6.6.3.1.2. E-Pharmacies
14.6.6.3.2. Offline
14.6.6.3.2.1. Hospital
Pharmacies
14.6.6.3.2.2. Retail
Pharmacies
14.6.6.4. South Korea Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.6.4.1. Residential
14.6.6.4.2. Commercial (Hospitals, Labs, etc.)
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.7.1.1. Blood Glucose Monitoring
14.6.7.1.1.1. Continuous
Glucose Monitors
14.6.7.1.1.2. Self-monitoring
Meters
14.6.7.1.1.3. Sensors
and Transmitters
14.6.7.1.2. Insulin Delivery
14.6.7.1.2.1. Insulin
Pumps
14.6.7.1.2.2. Injection
Pens
14.6.7.1.2.3. Syringes
14.6.7.1.2.4. Jet
injectors
14.6.7.2. Southeast Asia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Operation Type
14.6.7.2.1. Invasive
14.6.7.2.2. Non-Invasive
14.6.7.3. Southeast Asia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
14.6.7.3.1. Online
14.6.7.3.1.1. E-Commerce
14.6.7.3.1.2. E-Pharmacies
14.6.7.3.2. Offline
14.6.7.3.2.1. Hospital
Pharmacies
14.6.7.3.2.2. Retail
Pharmacies
14.6.7.4. Southeast Asia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.7.4.1. Residential
14.6.7.4.2. Commercial (Hospitals, Labs, etc.)
14.6.7.5. Southeast Asia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Offering
14.6.8.1.1. Blood Glucose Monitoring
14.6.8.1.1.1. Continuous
Glucose Monitors
14.6.8.1.1.2. Self-monitoring
Meters
14.6.8.1.1.3. Sensors
and Transmitters
14.6.8.1.2. Insulin Delivery
14.6.8.1.2.1. Insulin
Pumps
14.6.8.1.2.2. Injection
Pens
14.6.8.1.2.3. Syringes
14.6.8.1.2.4. Jet
injectors
14.6.8.2. Rest of Asia Pacific Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Operation Type
14.6.8.2.1. Invasive
14.6.8.2.2. Non-Invasive
14.6.8.3. Rest of Asia Pacific Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
14.6.8.3.1. Online
14.6.8.3.1.1. E-Commerce
14.6.8.3.1.2. E-Pharmacies
14.6.8.3.2. Offline
14.6.8.3.2.1. Hospital
Pharmacies
14.6.8.3.2.2. Retail
Pharmacies
14.6.8.4. Rest of Asia Pacific Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.8.4.1. Residential
14.6.8.4.2. Commercial (Hospitals, Labs, etc.)
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Offering
14.7.3. By
Operation Type
14.7.4. By
Sales Channel
14.7.5. By
Application
15. Middle East and Africa Diabetes Devices Market Analysis and
Forecasts, 2019 - 2027
15.1. Overview
15.1.1. Middle
East and Africa Diabetes Devices Market Revenue (US$ Mn)
15.2. Middle
East and Africa Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Offering
15.2.1. Blood
Glucose Monitoring
15.2.1.1. Continuous Glucose Monitors
15.2.1.2. Self-monitoring Meters
15.2.1.3. Sensors and Transmitters
15.2.2. Insulin
Delivery
15.2.2.1. Insulin Pumps
15.2.2.2. Injection Pens
15.2.2.3. Syringes
15.2.2.4. Jet injectors
15.3. Middle
East and Africa Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Operation Type
15.3.1. Invasive
15.3.2. Non-Invasive
15.4. Middle
East and Africa Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Sales Channel
15.4.1. Online
15.4.1.1. E-Commerce
15.4.1.2. E-Pharmacies
15.4.2. Offline
15.4.2.1. Hospital Pharmacies
15.4.2.2. Retail Pharmacies
15.5. Middle
East and Africa Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.1. Residential
15.5.2. Commercial
(Hospitals, Labs, etc.)
15.6. Middle
East and Africa Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Offering
15.6.1.1.1. Blood Glucose Monitoring
15.6.1.1.1.1. Continuous
Glucose Monitors
15.6.1.1.1.2. Self-monitoring
Meters
15.6.1.1.1.3. Sensors
and Transmitters
15.6.1.1.2. Insulin Delivery
15.6.1.1.2.1. Insulin
Pumps
15.6.1.1.2.2. Injection
Pens
15.6.1.1.2.3. Syringes
15.6.1.1.2.4. Jet
injectors
15.6.1.2. Saudi Arabia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Operation Type
15.6.1.2.1. Invasive
15.6.1.2.2. Non-Invasive
15.6.1.3. Saudi Arabia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
15.6.1.3.1. Online
15.6.1.3.1.1. E-Commerce
15.6.1.3.1.2. E-Pharmacies
15.6.1.3.2. Offline
15.6.1.3.2.1. Hospital
Pharmacies
15.6.1.3.2.2. Retail
Pharmacies
15.6.1.4. Saudi Arabia Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.1.4.1. Residential
15.6.1.4.2. Commercial (Hospitals, Labs, etc.)
15.6.2. UAE
15.6.2.1. UAE Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Offering
15.6.2.1.1. Blood Glucose Monitoring
15.6.2.1.1.1. Continuous
Glucose Monitors
15.6.2.1.1.2. Self-monitoring
Meters
15.6.2.1.1.3. Sensors
and Transmitters
15.6.2.1.2. Insulin Delivery
15.6.2.1.2.1. Insulin
Pumps
15.6.2.1.2.2. Injection
Pens
15.6.2.1.2.3. Syringes
15.6.2.1.2.4. Jet
injectors
15.6.2.2. UAE Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Operation Type
15.6.2.2.1. Invasive
15.6.2.2.2. Non-Invasive
15.6.2.3. UAE Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Sales Channel
15.6.2.3.1. Online
15.6.2.3.1.1. E-Commerce
15.6.2.3.1.2. E-Pharmacies
15.6.2.3.2. Offline
15.6.2.3.2.1. Hospital
Pharmacies
15.6.2.3.2.2. Retail
Pharmacies
15.6.2.4. UAE Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By
Application
15.6.2.4.1. Residential
15.6.2.4.2. Commercial (Hospitals, Labs, etc.)
15.6.3. Egypt
15.6.3.1. Egypt Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
15.6.3.1.1. Blood Glucose Monitoring
15.6.3.1.1.1. Continuous
Glucose Monitors
15.6.3.1.1.2. Self-monitoring
Meters
15.6.3.1.1.3. Sensors
and Transmitters
15.6.3.1.2. Insulin Delivery
15.6.3.1.2.1. Insulin
Pumps
15.6.3.1.2.2. Injection
Pens
15.6.3.1.2.3. Syringes
15.6.3.1.2.4. Jet
injectors
15.6.3.2. Egypt Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
15.6.3.2.1. Invasive
15.6.3.2.2. Non-Invasive
15.6.3.3. Egypt Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
15.6.3.3.1. Online
15.6.3.3.1.1. E-Commerce
15.6.3.3.1.2. E-Pharmacies
15.6.3.3.2. Offline
15.6.3.3.2.1. Hospital
Pharmacies
15.6.3.3.2.2. Retail
Pharmacies
15.6.3.4. Egypt Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
15.6.3.4.1. Residential
15.6.3.4.2. Commercial (Hospitals, Labs, etc.)
15.6.4. Kuwait
15.6.4.1. Kuwait Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
15.6.4.1.1. Blood Glucose Monitoring
15.6.4.1.1.1. Continuous
Glucose Monitors
15.6.4.1.1.2. Self-monitoring
Meters
15.6.4.1.1.3. Sensors
and Transmitters
15.6.4.1.2. Insulin Delivery
15.6.4.1.2.1. Insulin
Pumps
15.6.4.1.2.2. Injection
Pens
15.6.4.1.2.3. Syringes
15.6.4.1.2.4. Jet
injectors
15.6.4.2. Kuwait Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
15.6.4.2.1. Invasive
15.6.4.2.2. Non-Invasive
15.6.4.3. Kuwait Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
15.6.4.3.1. Online
15.6.4.3.1.1. E-Commerce
15.6.4.3.1.2. E-Pharmacies
15.6.4.3.2. Offline
15.6.4.3.2.1. Hospital
Pharmacies
15.6.4.3.2.2. Retail
Pharmacies
15.6.4.4. Kuwait Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
15.6.4.4.1. Residential
15.6.4.4.2. Commercial (Hospitals, Labs, etc.)
15.6.5. South
Africa
15.6.5.1. South Africa Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Offering
15.6.5.1.1. Blood Glucose Monitoring
15.6.5.1.1.1. Continuous
Glucose Monitors
15.6.5.1.1.2. Self-monitoring
Meters
15.6.5.1.1.3. Sensors
and Transmitters
15.6.5.1.2. Insulin Delivery
15.6.5.1.2.1. Insulin
Pumps
15.6.5.1.2.2. Injection
Pens
15.6.5.1.2.3. Syringes
15.6.5.1.2.4. Jet
injectors
15.6.5.2. South Africa Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Operation Type
15.6.5.2.1. Invasive
15.6.5.2.2. Non-Invasive
15.6.5.3. South Africa Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
15.6.5.3.1. Online
15.6.5.3.1.1. E-Commerce
15.6.5.3.1.2. E-Pharmacies
15.6.5.3.2. Offline
15.6.5.3.2.1. Hospital
Pharmacies
15.6.5.3.2.2. Retail
Pharmacies
15.6.5.4. South Africa Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.5.4.1. Residential
15.6.5.4.2. Commercial (Hospitals, Labs, etc.)
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Diabetes Devices Market
Revenue (US$ Mn) and Forecasts, By Offering
15.6.6.1.1. Blood Glucose Monitoring
15.6.6.1.1.1. Continuous
Glucose Monitors
15.6.6.1.1.2. Self-monitoring
Meters
15.6.6.1.1.3. Sensors
and Transmitters
15.6.6.1.2. Insulin Delivery
15.6.6.1.2.1. Insulin
Pumps
15.6.6.1.2.2. Injection
Pens
15.6.6.1.2.3. Syringes
15.6.6.1.2.4. Jet
injectors
15.6.6.2. Rest of Middle East & Africa Diabetes Devices Market
Revenue (US$ Mn) and Forecasts, By Operation Type
15.6.6.2.1. Invasive
15.6.6.2.2. Non-Invasive
15.6.6.3. Rest of Middle East & Africa Diabetes Devices Market
Revenue (US$ Mn) and Forecasts, By Sales Channel
15.6.6.3.1. Online
15.6.6.3.1.1. E-Commerce
15.6.6.3.1.2. E-Pharmacies
15.6.6.3.2. Offline
15.6.6.3.2.1. Hospital
Pharmacies
15.6.6.3.2.2. Retail
Pharmacies
15.6.6.4. Rest of Middle East & Africa Diabetes Devices Market
Revenue (US$ Mn) and Forecasts, By Application
15.6.6.4.1. Residential
15.6.6.4.2. Commercial (Hospitals, Labs, etc.)
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Offering
15.7.3. By
Operation Type
15.7.4. By
Sales Channel
15.7.5. By
Application
16. Latin America Diabetes Devices Market Analysis and Forecasts,
2019 - 2027
16.1. Overview
16.1.1. Latin
America Diabetes Devices Market Revenue (US$ Mn)
16.2. Latin
America Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Offering
16.2.1. Blood
Glucose Monitoring
16.2.1.1. Continuous Glucose Monitors
16.2.1.2. Self-monitoring Meters
16.2.1.3. Sensors and Transmitters
16.2.2. Insulin
Delivery
16.2.2.1. Insulin Pumps
16.2.2.2. Injection Pens
16.2.2.3. Syringes
16.2.2.4. Jet injectors
16.3. Latin
America Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Operation
Type
16.3.1. Invasive
16.3.2. Non-Invasive
16.4. Latin
America Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Sales
Channel
16.4.1. Online
16.4.1.1. E-Commerce
16.4.1.2. E-Pharmacies
16.4.2. Offline
16.4.2.1. Hospital Pharmacies
16.4.2.2. Retail Pharmacies
16.5. Latin
America Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Application
16.5.1. Residential
16.5.2. Commercial
(Hospitals, Labs, etc.)
16.6. Latin
America Diabetes Devices Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Offering
16.6.1.1.1. Blood Glucose Monitoring
16.6.1.1.1.1. Continuous
Glucose Monitors
16.6.1.1.1.2. Self-monitoring
Meters
16.6.1.1.1.3. Sensors
and Transmitters
16.6.1.1.2. Insulin Delivery
16.6.1.1.2.1. Insulin
Pumps
16.6.1.1.2.2. Injection
Pens
16.6.1.1.2.3. Syringes
16.6.1.1.2.4. Jet
injectors
16.6.1.2. Brazil Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Operation Type
16.6.1.2.1. Invasive
16.6.1.2.2. Non-Invasive
16.6.1.3. Brazil Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Sales Channel
16.6.1.3.1. Online
16.6.1.3.1.1. E-Commerce
16.6.1.3.1.2. E-Pharmacies
16.6.1.3.2. Offline
16.6.1.3.2.1. Hospital
Pharmacies
16.6.1.3.2.2. Retail
Pharmacies
16.6.1.4. Brazil Diabetes Devices Market Revenue (US$ Mn) and Forecasts,
By Application
16.6.1.4.1. Residential
16.6.1.4.2. Commercial (Hospitals, Labs, etc.)
16.6.2. Argentina
16.6.2.1. Argentina Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Offering
16.6.2.1.1. Blood Glucose Monitoring
16.6.2.1.1.1. Continuous
Glucose Monitors
16.6.2.1.1.2. Self-monitoring
Meters
16.6.2.1.1.3. Sensors
and Transmitters
16.6.2.1.2. Insulin Delivery
16.6.2.1.2.1. Insulin
Pumps
16.6.2.1.2.2. Injection
Pens
16.6.2.1.2.3. Syringes
16.6.2.1.2.4. Jet
injectors
16.6.2.2. Argentina Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Operation Type
16.6.2.2.1. Invasive
16.6.2.2.2. Non-Invasive
16.6.2.3. Argentina Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
16.6.2.3.1. Online
16.6.2.3.1.1. E-Commerce
16.6.2.3.1.2. E-Pharmacies
16.6.2.3.2. Offline
16.6.2.3.2.1. Hospital
Pharmacies
16.6.2.3.2.2. Retail
Pharmacies
16.6.2.4. Argentina Diabetes Devices Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.2.4.1. Residential
16.6.2.4.2. Commercial (Hospitals, Labs, etc.)
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Offering
16.6.3.1.1. Blood Glucose Monitoring
16.6.3.1.1.1. Continuous
Glucose Monitors
16.6.3.1.1.2. Self-monitoring
Meters
16.6.3.1.1.3. Sensors
and Transmitters
16.6.3.1.2. Insulin Delivery
16.6.3.1.2.1. Insulin
Pumps
16.6.3.1.2.2. Injection
Pens
16.6.3.1.2.3. Syringes
16.6.3.1.2.4. Jet
injectors
16.6.3.2. Rest of Latin America Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Operation Type
16.6.3.2.1. Invasive
16.6.3.2.2. Non-Invasive
16.6.3.3. Rest of Latin America Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
16.6.3.3.1. Online
16.6.3.3.1.1. E-Commerce
16.6.3.3.1.2. E-Pharmacies
16.6.3.3.2. Offline
16.6.3.3.2.1. Hospital
Pharmacies
16.6.3.3.2.2. Retail
Pharmacies
16.6.3.4. Rest of Latin America Diabetes Devices Market Revenue (US$ Mn)
and Forecasts, By Application
16.6.3.4.1. Residential
16.6.3.4.2. Commercial (Hospitals, Labs, etc.)
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Offering
16.7.3. By
Operation Type
16.7.4. By
Sales Channel
16.7.5. By
Application
17. Competitive Benchmarking
17.1. Brand
Benchmarking
17.2. Market
Share Analysis, 2018
17.3. Global
Presence and Growth Strategies
17.3.1. Mergers
and Acquisitions
17.3.2. Product
Launches
17.3.3. Investments
Trends
17.3.4. R&D
Initiatives
18. Player Profiles
18.1. Abbott,
Arkray, Inc.
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. B. Braun
Melsungen AG
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. Bayer
Corporation
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. BD
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. Dexcom
Inc.
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. F
Hoffmann-La Roche AG
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. iHealth
Labs Inc.
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. InsuJet,
Insulet Corporation
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. Integrity
Applications
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. LifeScan,
Inc.
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Medtronic
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business
Strategies
18.12. Nemaura
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business
Strategies
18.13. Novo
Nordisk
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business
Strategies
18.14. Sanofi
18.14.1. Company
Details
18.14.2. Company
Overview
18.14.3. Product
Offerings
18.14.4. Key
Developments
18.14.5. Financial
Analysis
18.14.6. SWOT
Analysis
18.14.7. Business
Strategies
18.15. Tandem
18.15.1. Company
Details
18.15.2. Company
Overview
18.15.3. Product
Offerings
18.15.4. Key
Developments
18.15.5. Financial
Analysis
18.15.6. SWOT
Analysis
18.15.7. Business
Strategies
18.16. Valeritas
Holdings Inc.
18.16.1. Company
Details
18.16.2. Company
Overview
18.16.3. Product
Offerings
18.16.4. Key
Developments
18.16.5. Financial
Analysis
18.16.6. SWOT
Analysis
18.16.7. Business
Strategies
18.17. Ypsomed
Holding AG
18.17.1. Company
Details
18.17.2. Company
Overview
18.17.3. Product
Offerings
18.17.4. Key
Developments
18.17.5. Financial
Analysis
18.17.6. SWOT Analysis
18.17.7. Business
Strategies
19. Key Findings
Note: This ToC is tentative and can
be changed according to the research study conducted during the course of
report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.